PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Saturday, May 31
    Trending
    • Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%
    • Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
    • IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25
    • Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers
    • WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law
    • Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth
    • Profin Range of Aluminium Profiles by Hafele
    • Business Outline Announces the Business Elite Award | Recognising Exceptional Business Leaders and Companies
    Submit News
    Twitter LinkedIn Instagram
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business

    Gujarat Inject (Kerala) Limited’s Q3 Net Profit Zooms By 4,500% & Declares Robust Q3 Results

    Naquiyah MaimoonNaquiyah Maimoon Business 3 Mins Read
    Gujarat
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Vadodara (Gujarat) [India], February 10: BSE-listed Gujarat Inject (Kerala) Limited (BSE: 524238), a leading agricultural company, reported a staggering increase of 4,500% in its net profit for the quarter ended December 2024.

    The company specializes in the trade of bulk vegetables and fruits, sourcing fresh produce directly from farmers and delivering it to shop owners, ensuring quality, freshness, and a seamless supply chain.

    Gujarat Inject (Kerala)’s net profit for the December 2024 quarter was Rs. 21.16 lakh, an increase of 45 times over the profit of Rs. 0.46 lakh in the corresponding quarter of the previous year. The company’s revenue in the December 2024 quarter was Rs. 315.23 lakh, compared to Rs. 21.59 lakh in the same quarter of the previous year, a growth of 1,360%.

    Highlights: 

    • For the first nine months of the fiscal year, the company demonstrated exceptional performance with a 2,007% rise in revenue to Rs. 1,480.86 lakh (from Rs. 36.96 lakh) and a 3,906% jump in net profit to Rs. 94.40 lakh (from Rs. 4.48 lakh).
    • The company reported nine months ended FY24-25 net profit at Rs. 94.40 lakh i.e. 11 times higher than the net profit of FY23-24.
    • The company reported a remarkable 4,500% surge in net profit for the quarter ended December 2024, reaching Rs. 21.16 lakh compared to Rs. 0.46 lakh in the same period last year.
    • The company’s revenue for the December 2024 quarter also witnessed impressive growth, increasing by 1,360% to Rs. 315.23 lakh from Rs. 21.59 lakh in the corresponding quarter of the previous year.

    For the nine months ended December 2024, Gujarat Inject (Kerala)’s revenue was Rs. 1,480.86 lakh as against Rs. 36.96 lakh in the corresponding period of the previous fiscal, a growth of 3,906%. The Net profit for the nine-month period was Rs. 94.40 lakh, 2,007% higher than the net profit of Rs. 4.48 lakh in the same period of the previous year.

    Gujarat Inject (Kerala)’s shares, having a face value of Rs. 10, closing price was Rs. 27.13 as on Friday, 7th Feb, 2025. The shares have seen a high of Rs. 28 and a low of Rs. 8.74 in the last 52 weeks. The company’s market capitalization is Rs. 39.04 crore. After a lack of significant activity in previous years, the company has shown improvement in performance over the last two years.

    The improved performance is also reflected in the share price, which is up by 35% in the past month. Additionally, trading volumes too have gone up, suggesting positive momentum in the stock.

    About Gujarat Inject (Kerala) Limited:

    Gujarat Inject (Kerala) Limited (BSE: 524238) is a distinguished name in the agricultural sector, specializing in the cultivation and distribution of premium-quality vegetables, fruits, and other agricultural produce. With a steadfast commitment to excellence, the company has demonstrated remarkable growth in recent years, marked by a strong financial performance and an expanding market presence. Gujarat Inject plays a pivotal role in the B2B segment, supplying fresh and superior-quality produce to businesses, shops and retailers. Through innovation, sustainability, and an unwavering focus on quality, the company continues to strengthen its position in the agribusiness landscape, fostering long-term value for shareholders and stakeholders.

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    500% By 4 Declares Robust Q3 Results Gujarat Inject (Kerala) Limited Q3 Net Profit Zooms
    Naquiyah Maimoon

    Keep Reading

    Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%

    Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

    IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25

    Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers

    WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth

    Recent Posts
    • Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%
    • Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
    • IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25
    • Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers
    • WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%

    31/05/2025

    Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

    31/05/2025

    IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25

    31/05/2025

    Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers

    30/05/2025

    WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    30/05/2025

    Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth

    30/05/2025
    Facebook Twitter Pinterest Vimeo WhatsApp TikTok Instagram

    MENU

    • Home
    • Business
    • Education
    • Home
    • Business
    • Education
    • National
    • Lifestyle

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2025 PNN Digital. Designed by Primex Media Services.
    • About Us
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.